Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025BloodOpen Access

SMARCC1 loss impairs differentiation and enhances self-renewal in ASXL1-mutant hematopoietic cells

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMineo Kurokawa

Discussion

Loading...

Member takes

Overview

CRISPR-Cas9 knockout reveals that smarcc1 loss impairs differentiation in asxl1-mutant hematopoietic cells, suggesting novel therapeutic targets.

Key Points

  • To explore the role of SMARCC1 loss in ASXL1-mutant hematopoietic cells and its implications for differentiation and self-renewal.
  • Performed CRISPR-Cas9 knockout on ASXL1-mutant cells
  • Analyzed self-renewal via colony-forming assays
  • Utilized public AML databases to evaluate SMARCC1 expression
  • Conducted flow cytometry for surface markers
  • Smarcc1 knockout enhanced self-renewal in ASXL1-mutant cells
  • Differentiation was impaired, evidenced by reduced Gr-1 positivity
  • SMARCC1 expression decreased in ASXL1-mutant AML compared to wild-type

Cite This Study

Mineo Kurokawa (2025) studied this question.

synapsesocial.com/papers/693624d74fa91c937236d0e2https://doi.org/10.1182/blood-2025-5008
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clone-specific epigenetic regulatory mechanisms in ASXL1-mutant chronic myelomonocytic leukemia2025
  2. 2Somatic ASXL1 mutations in chronic myelomonocytic leukemia result in loss of imprinting control and overexpression of DLK1 through deregulation of DNA methylation2025
  3. 3The long non-coding RNA WT1-AS controls differentiation programs and leukemic cell fate in AML2025
  4. 4SMARCD1 subunit of SWI/SNF chromatin remodeling complexes collaborates with p53 to exert an oncogenic role in B-ALL by maintaining high metabolic activity2025
  5. 5Prognostic impact of ASXL1 somatic mutation on patients with chronic myeloid leukemia: A systemic review and meta-analysis.2026